Medline shareholders price $2.13 billion secondary offering with $200 million concurrent repurchase

Medline Inc. announced that affiliated shareholders will sell 60 million Class A shares at $35.50 each, generating $2.13 billion. The underwriters may, within a 30‑day period, purchase up to an additional 9 million shares. The transaction is slated to close on November 23 2026, and Medline will buy back $200 million of stock from the sellers, receiving no proceeds itself.

The large secondary offering could increase the share supply and pressure the price, while the $200 million buy‑back may partially offset dilution. Investors should note the expected closing date and the optional extra shares that could further affect supply.

  • 1The offering price is $35.50 per share.
  • 260 million Class A shares are being sold.
  • 3The sale will raise $2.13 billion.
  • 4Underwriters have a 30‑day right to purchase up to 9 million additional shares.
  • 5The closing is scheduled for November 23 2026.
  • 6Medline will repurchase $200 million of stock from the selling shareholders.

Sources